Buy the Dip Alert: $BCTX should be on your radar and watchlist BriaCell progress update: Bria-OTS+, a next-gen off-the-shelf immunotherapy, continues development. Check the PR for full details: 
https://globenewswire.com/news-release/2025/0...ancer.html